Council inquiries follow June vote
Sheffield Children's NHS Foundation Trust is the only local trust to have said it uses Palantir. Council chief executive Kate Josephs sought answers from local NHS trusts after councilors voted in June against the £330 million agreement under which the US-based multinational would handle NHS patient data.
The June 24, 2026, resolution went beyond opposing the contract. According to a July council committee report, it urged the government to "exercise the break clause in NHS England's contract with Palantir, transitioning to a publicly owned, transparent, UK-based operator". Councilors also asked the Health Scrutiny Sub-Committee to question local trusts and the integrated care board about potential patient opt-outs, equality and measures to protect data.
Medact Sheffield has led the local campaign against Palantir's NHS role. The Star reports that Palantir routinely supplied US patients' medical data to assist deportations by the immigration enforcement agency ICE. It also reports that the company is deeply involved in Israeli military operations in Gaza.
Platform use and claimed benefits
The Sheffield responses come amid wider questions about which NHS organizations use the Federated Data Platform. On November 3, 2026, health-worker campaign group Medact reported that 29 trusts listed by NHS England as benefiting from it had said in Freedom of Information responses that they were not using it. According to The Register, those trusts account for about 21% of the 137 that NHS England lists as realizing benefits.
Palantir says its software is helping the NHS perform 100,000 additional operations, reduce discharge delays by 12% and remove 675,000 patients from waiting lists.
NHS Greater Manchester has deferred adoption at the Integrated Care Board level and is using its own Analytics and Data Science Platform instead, according to a Manchester City Council motion. That motion also cites a July 2026 NISTA report putting the Federated Data Platform's forecast whole-life costs at £1.08 billion and its forecast benefits at £808 million.
Data concerns and the contract deadline
The British Medical Association declared Palantir an unacceptable NHS partner in a motion passed in June 2025, as described in the Manchester council motion. The BMA urged doctors not to use the Federated Data Platform for non-direct care and advised general practitioners against signing new data-sharing agreements.
Patient opt-outs have also drawn scrutiny. The House of Commons Library reports that the National Data Guardian warned the government in October 2026 that recent increases in the National Data Opt-Out were "a concern". She noted that the increase coincided with media coverage of the platform and its suppliers, while stressing that a direct link could not be proved.
The government must decide by December 2026 whether to extend the platform contract with the Palantir-led consortium, according to the House of Commons Library. The option to end the agreement after its initial three-year term, commonly called the break clause, falls in March 2027.












